Patrick Soon-Shiong
Patrick Soon-Shiong is a South African-born American surgeon, medical researcher, and businessman who serves as founder and CEO of NantWorks and executive chairman of ImmunityBio. He is a minority owner of the Los Angeles Lakers, having purchased a 4% stake from Magic Johnson in 2010, and is the owner and executive chairman of the Los Angeles Times. He is best known for inventing Abraxane, a cancer drug used for lung, breast, and pancreatic cancer, and for receiving FDA approval in 2024 for the immunotherapy drug Anktiva for non-muscle invasive bladder cancer.
“Patrick Soon-Shiong said he doesn't plan to sell his 4% stake in the Los Angeles Lakers to the group led by Joshua Kushner and Bob Iger.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.